Target Hospitality (TH) shares slumped 44% amid heavy trading after the company said Monday it received a notice from the US government that it plans to discontinue the current Pecos Children's Center services agreement with Target's nonprofit partner.
Intraday trading volume soared to over 9.3 million shares from a daily average of about 489,000.
Invivyd (IVVD) said Monday that the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate COVID-19 in immunocompromised adults and adolescents.
Shares slid 23% as intraday trading volume stood at over 11.7 million compared with the stock's daily average of about 14.8 million.
Summit Therapeutics (SMMT) shares dropped 13% after the company reported a Q4 non-GAAP net loss of $0.07 per diluted share, widening from a loss of $0.04 a year earlier.
More than 4.74 million shares traded intraday versus its daily average of roughly 2.23 million.
Price: 5.25, Change: -4.11, Percent Change: -43.91
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。